Welcome World Pharmaceutical （China）Summit 2012

Who We Are
QIAGEN is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA, and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.
We have developed and market more than 500 sample and assay products as well as automated solutions for such consumables. The company provides these products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as a "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer, as well as a broad suite of solutions for infectious disease testing and companion diagnostics.
As of December 31, 2011 QIAGEN employed nearly 3,900 people in over 35 locations worldwide.

日立数据系统提供世界一流的信息技术、服务和解决方案，从而帮助用户实现显著的投资回报（ROI）和卓越的资产回报（ROA），并满足用户的业务需求。秉持着令信息技术实现全面虚拟化、全面自动化、支持云计算和可持续发展的愿景，日立数据系统不断提供能够减少IT成本、提高IT灵活性的解决方案。日立数据系统在全球拥有 4700 多名员工，业务遍及 100 多个国家和地区。公司的产品、服务和解决方案深受全球领先企业的信赖，其中包括超过 70% 的财富 100 强企业和80%多的财富全球100强企业。日立数据系统相信：数据驱动世界，信息缔造财富。更多信息，敬请访问：www.hds.com

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries.

Fountain Medical Development Corp. is a contract research organization (CRO) offering a full range of ICH GCP compliant clinical research services for multinational clients conducting clinical research in China. The management team of Fountain has decades of combined experience working with the world's leading CRO's and drug developers. In the Chinese CRO market, we fill the void of a service provider that balances high quality with moderate cost.
Our extensive global experience in multiple therapeutic areas is unmatched by other local CRO's, and our lower operational cost allows us to pass significant savings on to our clients.
In addition to the founders, we have assembled the highest quality team that is capable of handing regulatory affairs, clinical operations, safety, project management, data management and statistical analysis. Furthermore, through our internal team and a global network of consultants, we are one of the only local CRO’s capable of global standard clinical trial protocol design.
In summary, we have been service providers, we have hands-on clinical trial experiences in both China and the US, and client success is our passion. We believe that experience, responsiveness, flexibility and attention to details are the cornerstones of successful product development.
Our Services
*       Phase I-IV Drug and Device Trials
*       Central Lab Operation
*       Consulting & Project Management
*       Clinical Operations &Laboratory Services
*       Clinical Trial Designs & Site Management
*       Data Management & Biostatistics
*       Safety Handling(Coding, Assessment, DSMB)
*       EDC(Electronic Data Capture)
*       Pharmacoeconomic Studies
*       Regulatory Affairs & Market Launch Preparation

Name: Fountain medical development Limited
Address: Room 403, Building TongChengDa, 26 Jing An li, Chaoyang District, Beijing, China
Website: www.fountain-med.com
Contact name: Joanne Jiang
Email address: joanne.jiang@fountain-med.com

Merck Millipore, a division of Merck KGaA, Darmstadt, Germany, offers solutions that enable scientists to conduct life science research easily, efficiently and economically. With a range of more than 40,000 products, Merck Millipore is one of the top three suppliers of tools to the life science industry. As the Life Science Division of Merck KGaA, Merck Millipore:
       Creates a more than €2.5 billion global business with broad capabilities and deep expertise across research, development, and manufacturing value chain in 2010.
       Is one of the top 3 investors in innovation in Life Science Tools and is committed to combine our capabilities to bring proven products and more advanced, integrated solutions to improve the productivity and efficiency of our customer work.
       Will leverage our enhanced global manufacturing and distribution capabilities to ensure the best quality and reliability from our supply chain.
       Will continue to be the trusted partner for services and support combining the benefits of global scale and local proximity.

ADICON Clinical Laboratories, Inc. is the leading independent clinical reference laboratory in China. The initial clinical laboratory was launched by a group of Chinese experts who were trained in the United States, with preeminent management experience. Their expertise included a wide variety of diagnostic testing, clinical trials, and physical examination services. With the strong support of ACON Laboratories, one of the leading diagnostic companies in the United States, ADICON formed close relationships with medical institutes and clinical labs all over the world. These partnerships and collaborations provided ADICON with advanced diagnostics technologies and updated lab management systems. We are constantly seeking new technologies and business partnerships around the world to provide world-class diagnostic services in China.

尼康仪器（上海）有限公司 Nikon microscopes enable observation of the behavior of live organisms at the nanometer scale Nikon offers a diverse lineup of microscopes for a broad spectrum of applications, from education and lab training to clinical and research use. In response to growing demand for live cell imaging, we’ve developed systems built around confocal and inverted microscopes. Nikon has created Super Resolution Microscopes that utilize top-level optical technologies, greatly surpass the conventional resolution limits of optical microscopes and enable a view of the nanostructures of living cells at a molecular scale. Other unique systems already available in the market include the Perfect Focus System (PFS), which automatically corrects the focus drift of live cell images when the images are recorded over an extended period, and the BioStation series of systems used for cultivation and observation of cell samples. Thus, Nikon is contributing to the study and research of biology, and is working to expand its bio-related business as a whole. To meet the increasing demand for Nikon products in Chinese market, Nikon Corporation decided to launch its branch company in China. Therefore, in April 2003, NIKON Instruments (Shanghai) Co., Ltd. was established, and opened its own branch companies at Beijing and Guangzhou shortly afterwards. As a part of Nikon Corporation, NIKON Instruments (Shanghai) wish to make better cooperation with our honorable users in China. Website: www.nikon-instruments.com.cn

Eliving was founded in 2001, which is a full-service Contract Research Organization (CRO) with nearly 300 employees in China, providing time-saving expertise and trial management for clinical and regulatory needs. Eliving headquarters in Hunnan High-tech District, Shenyang city where our central labs with CNAS qualification are located. The Beijing and Shanghai branches are the operational centers, followed by fifteen offices in China, to manage clinical researches across the country. The Beijing branch focuses on domestic business and regulatory affairs, while the Shanghai branch is for the collaborations with multinational enterprises. Eliving organized the strategic alliances with 11 national clinical sites in Liaoning province-Liaoning Clinical Research Alliances (LCRA), and set up the international comprehensive clinical evaluation & service platform-Liaoning Clinical Research Center (LCRC). The unique management of sites, extensive network with hospitals and unparalleled insight to Chinese regulatory affairs are the foundations for Eliving’s constant successes. Since 2001, more than 400 projects have been completed by Eliving for over 100 clients, with reduced timelines and enhanced productivity and quality. The company goal is to become the most preferred CRO doing clinical trials in China.

Kunming Biomed International (KBI) is a contract research organization providing preclinical research services, specialized on non-human primates. The core competency of KBI stems from our expertise in developing and running specialized primate animal models to test drug candidates and medical devices for their pharmacological effects and biocompatible repairs. A large animal colony combined with experienced research and scientific study teams can offer “one-stop service” which ensures quality. We also conduct adjacency studies in PK/PD, in vivo pharmacology and preliminary toxicology. KBI offers cost effective study of the highest quality while applying the highest standards of animal welfare and animal ethics. KBI website: www.kbimed.com

PHARMACONS is an established Contract Research Organization comprising a group of experienced and enthusiastic professionals at all levels from global pharmaceutical, biotechnology and CRO companies. We operate in Australia, Belgium and China with associates in America, Japan and other Asia countries. This is one CRO company which truly understands the needs and processes of pharmaceutical and biotechnology companies. PHARMACONS provides contract clinical research and development services, workable solutions and client satisfaction to your R&D needs. We offer viable strategies, plans, solutions, quality and timely results which allow you to achieve shorter time to market and speed to value. PHARMACONS has the systems and processes supported with our long-term experience and the skills of our people in the region. PHARMACONS has successfully established Oracle Clinical and its Remote Data Capture systems in China which will benefit our sponsors in improving data quality, efficiency and cost savings. PHARMACONS is determined to become a top quality CRO in Asia-Pacific region.

生物医药产业作为济南高新区重点发展的产业之一，在新药研发、成果转化和实施产业化方面居全省领先地位，自身具有独特的发展优势。
目前，园区生物医药企业已占到全市的85%、全省的60%，涉及化药、中药、医疗器械、民族药物、现代医药物流等。截至2011年12月，区内生物医药企业共270家，实现销售收入200亿元，其中销售收入过十亿元企业4家；过五亿元企业1家；过亿元企业共18家；过五千万企业13家；过千万元企业36家，规模以上企业达到52家。
济南高新区作为国家中长期科技规划科技重大专项国家综合性新药研发技术大平台和国家创新药物孵化基地的承担单位，累计承担各级各类科技计划项目174项，其中国家级项目85项，省级项目89项；累计申请国内专利419项；省级以上工程技术研究中心、企业技术中心共有30家，其中国家级2家；累计完成成果转化1000余项，申报国家一类新药9项、二类以下新药和生物制剂60余项。
济南高新区根据生物医药产业布局特点，按照“三位一体”的发展思路，同时在中心区、出口加工区、两河片区建设了生物医药孵化起步区、科研中试区、产业示范区。济南高新区启动规划建设万亩生物医药产业区，一期规划面积1040亩。通过集中开发链条式发展的建设思路，将逐步形成技术链和产业链相衔接完整的医药创新发展产业体系，打造华东地区规模最大、自主创新能力最强的“济南药谷”和医药产业物流配套完善的“济南药城”。

Introduction of Bioknow Co., Ltd
Bioknow- Total solutions for med-pharma informatics
Beijing Bioknow Information technology Co., Ltd is dedicating to provide med-pharma information integrated solutions. We developed BioKnow Universal Application Platform (Bioknow-UAP) for Information management and analysis framework system originally. Bioknow UAP platform based on component standardization and customization concept can be customized to meet specific needs of users.
Products introduction
There are several software including BioKnow-GCPData, BioKnow-GCPProject, BioKnow-IWRS, Bioknow-sample, BioKnow-MolNet . The function of the system involves medical sample management, clinical trial data management, lab management, animal management, sequence data management and molecule function annotation. The solutions provide perfect total information solutions for medical investigators and improve the efficiency and quality of their work greatly.
Bioknow-UAP Platform
The platform is built based on J2EE and MVC framework and has high security, easily extensible, easily maintenance and cross-platform advantages. The system is also bilingual (Chinese and English) and supports multi-database such as Oracle, SQLServer and MySQL. Users visit the system by website. Support services
We will provide comprehensive technical training, customization, maintenance and online update services by remote technical support, and all of the services are free during the term of contract.

Wincon is an AAALAC-accredited CRO providing non-human primate related services for the development of drugs, cell and gene therapies, and medical device. We developed a variety of disease models in non-human primates, and our service covers studies in discovery of biomarkers and drug targets, non-GLP DMPK and toxicity, efficacy, drug delivery and devices development.
Our highly specialized NHP Disease Models and Services including:
* CNS Diseases: Parkinson’s Disease, Dyskinesia, Cognition(CANTAB), Aging Studies, Lesion of Specific Functional Neurons, Spinocerebellar Ataxia
* Metabolic Diseases: Type I and Type II Diabetes, Obesity, Atherosclerosis, Dyslipidemia
* Osteoarthritis Diseases: Meniscal tear/ACLT, Natural occurring OA, Banking of NHP joint tissues
* Ophthalmological Diseases: NHP IOP Study, Glaucoma Model Induced By Bead and Virus Vector Injection, Glaucoma Model Induced by Argon Laser
We aim to form long-term seamless partnerships with our clients, by offering our unparalleled expertise, experience, and services.
Wincon Website: www.winconlab.com

Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise. Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division. Leica Microsystems' Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory. The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.
www.leica-microsystems.com

Changsha JiYuan Computer Co., LTD is a professional services and technology consulting ?rm that started in 2008 with an experienced staff, an entrepreneurial spirit, and a passion for solving complex business and technology problems.
JiYuan specializes in custom software application development for clinical trials and knowledge management solutions for multiple vertical markets. JiYuan has demonstrated success with multiple customers in the pharmaceutical arena, government, universities, and large and small corporations worldwide. We deliver intelligent, efficient applications that enhance an organization’s ability to navigate the increasingly complex issues and opportunities that technology brings to business. We ensure on-time delivery by providing full lifecycle software application development, including system architecture, design, development, quality assurance, documentation, and support. JiYuan achieved Capability Maturity Model Integration (CMMI) Level 3 certification to ensure our customers’ that we use only proven processes and full accountability to reduce development risk.

Shandong International Biotechnology Park is built in collaboration by Management Committee of Yantai High-Tech Zone and Shandong Luye Pharma Group Ltd. in support of Department of Science and Technology of Shandong Province and Yantai Municipal Government. Total area is 172 acres, which will be divided into the R&D Area and the Living Area . Total construction area will be 1,070,000m2, of which 560,000m2 will be for buildings in the R&D section. Shandong International Biotechnology Park occupies the central area of Yantai High-Tech Zone. Designed by a world-class company, the Park will focus on R&D in three main areas: Bio-pharma, Marine Biology and Biological Agriculture. A series of shared R&D platforms will be available to serve the companies in the Park.